Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 15;25(4):133. doi: 10.3892/ol.2023.13719

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Zhong et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 1. — CTHRC1 expression levels in different types of human cancer. (A) The transcription levels of human CTHRC1 in different tumor types in the TCGA database were assessed using TIMER. (B) CTHRC1 transcriptional levels in adjacent and tumor tissues in patients with HNSCC from the TCGA database. (C) Expression level of CTHRC1 in different cancer datasets compared with normal tissues in the ONCOMINE database, the number indicated the number of data sets included by The National Center for Biotechnology Information that matched the conditions. (D) Scatter plot of CTHRC1 expression (using H-score) in HNSCC tissues compared with normal tissues. (E) Representative immunohistochemistry of CTHRC1 in clinical specimens. *P<0.05, **P<0.01, ***P<0.001. TCGA, The Cancer Genome Atlas; ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL, cholangio carcinoma; CNS, central nervous system; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B-cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; HPV, human papillomavirus; neg, negative; pos, positive; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LGG, (brain) lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; MESO, mesothelioma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PCPG, pheochromocytoma and paraganglioma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SARC, sarcoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumor; THCA, thyroid carcinoma; THYM, thymoma, UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma; UVM, uveal melanoma; CTHRC1, collagen triple helix repeat containing 1; TPM, transcripts per million.